Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/575,850US6509327B1 (en) | 1998-09-30 | 2000-05-19 | Compositions and methods for treating otic, ophthalmic and nasal infections |
US09575850 | 2000-05-19 | ||
PCT/US2001/016112WO2001089496A2 (en) | 2000-05-19 | 2001-05-17 | Compositions and methods for treating otic, ophthalmic and nasal infections comprising quinolone antibiotics |
Publication Number | Publication Date |
---|---|
AU2001261752A1true AU2001261752A1 (en) | 2001-12-03 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261752AAbandonedAU2001261752A1 (en) | 2000-05-19 | 2001-05-17 | Compositions and methods for treating otic, ophthalmic and nasal infections |
Country | Link |
---|---|
US (2) | US6509327B1 (en) |
AU (1) | AU2001261752A1 (en) |
WO (1) | WO2001089496A2 (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
EP1226138B1 (en) | 1999-10-08 | 2004-12-29 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
WO2003088897A2 (en)* | 2001-04-06 | 2003-10-30 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
US7790709B2 (en) | 2002-12-06 | 2010-09-07 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
US7842791B2 (en)* | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
EP1608377B1 (en) | 2003-03-17 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
US20050009931A1 (en)* | 2003-03-20 | 2005-01-13 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20050004098A1 (en)* | 2003-03-20 | 2005-01-06 | Britten Nancy Jean | Dispersible formulation of an anti-inflammatory agent |
AU2004222523A1 (en)* | 2003-03-20 | 2004-09-30 | Pharmacia Corporation | Dispersible formulation of an anti-inflammatory agent |
US20040214753A1 (en)* | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20040202687A1 (en)* | 2003-04-14 | 2004-10-14 | Babu M.K. Manoj | Ciprofloxacin formulations and methods of making and using the same |
US20050085446A1 (en)* | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
AU2004272414B2 (en) | 2003-09-10 | 2009-05-28 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US20070020298A1 (en)* | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
PT1828167E (en) | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Acrylamide derivatives as antibiotic agents |
AT501376B1 (en)* | 2005-01-17 | 2010-11-15 | Pregenzer Bruno | GLUCCOOCORTICOID MEDICINAL PRODUCT |
US8337481B2 (en) | 2005-01-25 | 2012-12-25 | Patrick Slater | Method for treating otitis externa |
US7981104B2 (en)* | 2005-01-25 | 2011-07-19 | Patrick Slater | Method for treating otitis externa |
US20090156578A1 (en)* | 2005-12-05 | 2009-06-18 | PAULS Henry | 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
EP2054422B1 (en) | 2006-07-20 | 2017-06-14 | Debiopharm International SA | Acrylamide derivatives as fab i inhibitors |
WO2008098374A1 (en) | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
US8222407B2 (en)* | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
ES2493641T3 (en)* | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Nasal administration of aqueous corticosteroid solutions |
CA2714580A1 (en)* | 2008-02-15 | 2009-08-20 | Alcon Research, Ltd. | Fluoroquinolone derivatives for ophthalmic applications |
RU2469726C2 (en) | 2008-05-14 | 2012-12-20 | Отономи, Инк. | Corticosteroid-based composition with controlled release for treatment of ear diseases |
US20100016450A1 (en)* | 2008-07-21 | 2010-01-21 | Otonomy, Inc. | Controlled release delivery devices for the treatment of otic disorders |
US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
CA2765852C (en)* | 2009-07-02 | 2014-08-26 | Alcon Research, Ltd. | Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
EP2802209B1 (en)* | 2012-01-10 | 2020-12-02 | Entrx LLC | Otic formulations |
SMT201900411T1 (en) | 2012-06-19 | 2019-09-09 | Debiopharm Int Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
US9504691B2 (en)* | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
US9849126B2 (en) | 2013-01-03 | 2017-12-26 | Entrx LLC | Sterile otic formulations |
CN105682742A (en) | 2013-08-27 | 2016-06-15 | 奥德纳米有限公司 | Treatment of pediatric otic disorders |
US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
CN108778286A (en) | 2016-02-26 | 2018-11-09 | 德彪药业国际股份公司 | Medicine for treating diabetic foot infection |
US11040004B2 (en) | 2016-09-16 | 2021-06-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
CN119587480A (en) | 2020-02-06 | 2025-03-11 | 视尔普斯眼科公司 | Compositions and methods for treating eye diseases |
KR20240142585A (en) | 2020-03-25 | 2024-09-30 | 오큘라 테라퓨틱스, 인코포레이티드 | Ocular implant containing a tyrosine kinase inhibitor |
EP4142664A4 (en) | 2020-04-27 | 2024-05-29 | Ocular Therapeutix, Inc. | Methods of treating allergic conjunctivitis |
ES2975148T3 (en) | 2020-09-24 | 2024-07-03 | Ocular Therapeutix Inc | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine |
EP4216929A1 (en) | 2020-09-24 | 2023-08-02 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
US4670444B1 (en) | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US4730013A (en) | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
US4551456A (en) | 1983-11-14 | 1985-11-05 | Merck & Co., Inc. | Ophthalmic use of norfloxacin and related antibiotics |
US5223493A (en) | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
JPH089597B2 (en) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 8-Alkoxyquinolonecarboxylic acid excellent in selective toxicity and its salt, and method for producing the same |
DE3704907A1 (en) | 1987-02-17 | 1988-08-25 | Bayer Ag | TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS |
US5563138A (en) | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
US4920120A (en) | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
US5149694A (en) | 1988-03-09 | 1992-09-22 | Alcon Laboratories, Inc. | Combination of tobramycin and dexamethasone for topical ophthalmic use |
DE3906365A1 (en) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM |
WO1990001933A1 (en) | 1988-08-26 | 1990-03-08 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
US5360611A (en) | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
US5185337A (en) | 1989-03-29 | 1993-02-09 | Otsuka Pharmaceutical Co., Ltd. | Pyrroloquinoline derivatives and pharmaceutical compositions for antimicrobial use |
US5164402A (en) | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
TW209865B (en) | 1992-01-10 | 1993-07-21 | Bayer Ag | |
ES2079994B1 (en)* | 1992-10-07 | 1996-08-01 | Cusi Lab | PHARMACEUTICAL FORMULATION BASED ON POLYMIXINE-TRIMETOPRIM AND AN ANTI-INFLAMMATORY AGENT FOR ITS TOPICAL OPHTHALMIC AND ETHICAL USE. |
DE4234078A1 (en) | 1992-10-09 | 1994-04-14 | Bayer Ag | Quinolonecarboxylic acids |
US5631004A (en) | 1993-09-30 | 1997-05-20 | Alcon Laboratories, Inc. | Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
US5540930A (en) | 1993-10-25 | 1996-07-30 | Pharmos Corporation | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
ES2079320B1 (en) | 1994-05-17 | 1996-10-16 | Cusi Lab | OPHTHALMIC DISSOLUTION BASED ON A DICLOFENACO AND TOBRAMYCIN AND ITS APPLICATIONS. |
DE4424369A1 (en) | 1994-07-11 | 1996-01-18 | Bayer Ag | Pyrido [3,2,1.i, j] [3,1] benzoxazine derivatives |
EP0782448B1 (en) | 1995-06-06 | 2002-03-27 | Bayer Aktiengesellschaft | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
DE19546249A1 (en) | 1995-12-12 | 1997-06-19 | Bayer Ag | New crystal modification of 1-cyclopropyl-7 - ([S, S] -2,8-diazabicyclo [4,3,0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4 -oxo-3-quinoline carboxylic acid hydrochloride (CDCH), process for its preparation and pharmaceutical preparations containing it |
WO1998006435A2 (en) | 1996-08-14 | 1998-02-19 | Vanderbilt University | COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
CN1623533A (en) | 1997-09-25 | 2005-06-08 | 拜尔公司 | Drug formulation with controlled release of active ingredient |
US5912255A (en) | 1998-02-27 | 1999-06-15 | Bussell; Letantia | Topical fluoroquinolone antibiotics combined with benzoyl peroxide |
GB9818258D0 (en) | 1998-08-21 | 1998-10-14 | Pfizer Ltd | Antifungal compositions |
CA2307632C (en) | 1998-08-21 | 2007-05-22 | Senju Pharmaceutical Co., Ltd. | Aqueous liquid pharmaceutical composition |
US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
AR020661A1 (en) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
AR020660A1 (en) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF EYES, EARS AND NOSE |
EP1117406A1 (en) | 1998-09-30 | 2001-07-25 | Alcon Laboratories, Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
US6093417A (en)* | 1999-01-11 | 2000-07-25 | Advanced Medical Instruments | Composition to treat ear disorders |
DE19962470A1 (en) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Use of chemotherapy drugs |
WO2001089495A2 (en) | 2000-05-19 | 2001-11-29 | Alcon Laboratories, Inc. | Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
Publication number | Publication date |
---|---|
US20030069253A1 (en) | 2003-04-10 |
US6509327B1 (en) | 2003-01-21 |
WO2001089496A3 (en) | 2002-04-25 |
WO2001089496A2 (en) | 2001-11-29 |
Publication | Publication Date | Title |
---|---|---|
AU2001261752A1 (en) | Compositions and methods for treating otic, ophthalmic and nasal infections | |
AU2001228759A1 (en) | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols | |
AU2001245437A1 (en) | Lightweight methods and compositions for well treating | |
AU2001268564A1 (en) | Alpha-glycosylceramides for treating bacterial and fungal infections | |
AU2001269799A1 (en) | Methods for treating various eye disorders | |
AU2001289684A1 (en) | Glass-ceramics, process for their preparation and use | |
AU2001239774A1 (en) | Antibacterial agents and compositions, methods and systems employing same | |
AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
AU2001253297A1 (en) | Sterilization process for air, liquid and surfaces | |
AU2001237939A1 (en) | Methods for treating glaucoma | |
AU2001275085A1 (en) | Methods, compounds and compositions for treating gout | |
AU2003296963A1 (en) | Methods and compositions for treating and preventing ear infections | |
AU2001277824A1 (en) | Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation | |
AU2002324753A1 (en) | Composition and method for treating viral infection | |
AU2002241670A1 (en) | Method for treating glaucoma IB | |
AU2002353774A1 (en) | Products and methods for treating microbial infections | |
AU2001261748A1 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
AU2001234616A1 (en) | Vaccine composition, process and methods | |
AU2003237088A1 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
AU2001249965A1 (en) | Durable sb-stabilized mo+w phosphate glasses | |
AU2001258675A1 (en) | Treating infections | |
AU2002350181A1 (en) | Compositions and methods for viral delivery | |
AU2002342188A1 (en) | Methods and compositions for treating flavivirus-mediated disease | |
AU2001211674A1 (en) | Naphthomelanins, process for their preparation and compositions thereof | |
AU2002353915A1 (en) | Methods and compositions for treating rotavirus-mediated disease |